EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR

Author(s)

• 

  Matthew L. Hemming, MD PhD

  Assistant Professor
  UMass Chan Medical School
  Worcester, Massachusetts, United States

  Slides

Co-Author(s)

• SB

  Shahid Banday, PhD

  UMass Chan Medical School
  Worcester, Massachusetts, United States
• ES

  Ewa T. Sicinska, MD

  Dana-Farber
  Boston, Massachusetts, United States
• BP

  Boryana Petrova, PhD

  Boston Children's Hospital
  Boston, Massachusetts, United States
• KA

  Kathryn Abell, BS

  Cell Signaling Technology
  Danvers, Massachusetts, United States
• TY

  Tomer Yaron, PhD

  Weill Cornell Medicine
  New York, New York, United States
• EH

  Emily Huntsman, MS

  Weill Cornell Medicine
  New York, New York, United States
• JK

  Joseph Kerfoot, n/a

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• JJ

  Jared Johnson, PhD

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• AN

  Alissa Nelson, PhD

  Cell Signaling Technology
  Danvers, Massachusetts, United States
• MS

  Matthew Stokes, PhD

  Cell Signaling Technology
  Danvers, Massachusetts, United States
• SB

  Sean Beausoleil, PhD

  Cell Signaling Technology
  Danver, Massachusetts, United States
• LC

  Lewis Cantley, PhD

  Harvard Medical School
  Boston, Massachusetts, United States
• NK

  Naama Kanarek, PhD

  Children's Hospital Boston
  Boston, Massachusetts, United States
• AA

  Andrea An, n/a

  Cell Signaling Technology
  Danvers, Massachusetts, United States
• TL

  Tyler Levy, MA

  Cell Signaling Technology
  Danvers, Massachusetts, United States